Growing Awareness Of Eye Illnesses Drives Growth In The Market: A Key Factor Shaping the Future of the Open-Angle Glaucoma (OAG) Market in 2025

What market dynamics are playing a key role in accelerating the growth of the open-angle glaucoma (oag) market?
As more people become aware of the increasing prevalence of eye diseases, it is anticipated that the open-angle glaucoma (OAG) market will grow significantly. Eye diseases can range from minor issues such as dry eyes to severe conditions like glaucoma and macular degeneration, all of which can impact the structure, function, and vision of the eyes. Factors like aging populations, extensive screen time, an increase in diabetes, environmental pollution, and lifestyle choices that negatively affect eye health are contributing to their rise. Open-angle glaucoma (OAG) is a noteworthy example, being a primary reason for blindness, predominantly in older adults. This emphasizes the importance of regular eye check-ups, early detection, and preventive care to aid in avoiding irreversible vision loss. The Royal National Institute of Blind People (RNIB), a sight loss charity based in the UK, reported in October 2023 that over eight million eye care outpatient appointments were made in the UK during 2021/22, rendering it the most sought-after specialty. Furthermore, the number of people experiencing vision loss, which currently exceeds two million, is expected to increase to over four million by 2050. Consequently, the increased awareness of eye diseases is fueling the growth of the open-angle glaucoma (OAG) market.

Get Your Open-Angle Glaucoma (OAG) Market Report Here:
https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

How will the growth rate of the open-angle glaucoma (oag) market shape industry trends by 2034?
The market size for open-angle glaucoma (OAG) has spectaculary expanded in the recent past. The growth is expected to continue, rising from $6.13 billion in 2024 to $6.55 billion in 2025, marking a compound annual growth rate (CAGR) of 6.8%. This historical expansion is due to factors such as the escalating incidence of glaucoma in elderly populations, heightened discernment regarding early detection of ocular diseases, an increase in health care spending, governmental involvement in vision care schemes, and the global development of ophthalmology practices.

The market for open-angle glaucoma (OAG) is slated to experience robust growth in the upcoming years, with projections of it reaching a value of $8.42 billion by 2029, delivering a compound annual growth rate (CAGR) of 6.5%. The surge in market size during the forecast period can be attributed to a plethora of factors such as the increasing need for combined therapies, heightened attention towards personalized health care, advancement in reimbursement policies for glaucoma treatments, the rise in lifestyle-related eye disorders, and increasing demand for non-intrusive diagnosis methods. Prominent trends during the forecast period are expected to include the advancement of AI in glaucoma detection, a transition towards outpatient surgical procedures for glaucoma, growing adoption of sustained-release glaucoma implants, the incorporation of wearable technology to track intraocular pressure, and an amplified emphasis on sustainability in the production of medical devices.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

What trends are poised to drive the future success of the open-angle glaucoma (oag) market?
Leading businesses in the open-angle glaucoma (OAG) market are focusing their efforts on the creation of groundbreaking solutions such as minimally invasive glaucoma devices (MIGDs). These technologies serve as a superior and less invasive option for managing primary open-angle glaucoma and minimizing dependence on conventional treatments. MIGDs encompass a variety of surgical implants and methods specifically designed to decrease intraocular pressure in glaucoma patients by means of small incisions and minor disruption to ocular tissues. For example, in December 2023, iSTAR Medical, a medtech firm based in Belgium, introduced MINIject in the Netherlands. This innovative treatment for primary open-angle glaucoma employs a distinctive porous STAR material to improve fluid drainage and lower IOP. MINIject, by lessening the reliance on traditional therapies, represents a substantial advancement in glaucoma treatment, providing a safer and more efficient management approach for this primary source of irreversible blindness.

Which primary segments of the open-angle glaucoma (oag) market are driving growth and industry transformations?
The open-angle glaucoma (OAG) market covered in this report is segmented -

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type
2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class
3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:
1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma
2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma
3) By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20911

Which geographical regions are pioneering growth in the open-angle glaucoma (oag) market?
North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the influential players reshaping the open-angle glaucoma (oag) market landscape?
Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

What Is Covered In The Open-Angle Glaucoma (OAG) Global Market Report?

•Market Size Forecast: Examine the open-angle glaucoma (oag) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the open-angle glaucoma (oag) market for a structured understanding.
•Key Players Overview: Analyze major players in the open-angle glaucoma (oag) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the open-angle glaucoma (oag) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the open-angle glaucoma (oag) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the open-angle glaucoma (oag) market.
•Industry Challenges: Identify potential risks and obstacles affecting the open-angle glaucoma (oag) market.
•Competitive Landscape: Review strategic developments in the open-angle glaucoma (oag) market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.